Literature DB >> 19900755

Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Denise A B Smith1, Sampada S Vaidya, Jonathan A Kopechek, Shao-Ling Huang, Melvin E Klegerman, David D McPherson, Christy K Holland.   

Abstract

Echogenic liposomes (ELIP) were developed as ultrasound-triggered targeted drug or gene delivery vehicles (Lanza et al. 1997; Huang et al. 2001). Recombinant tissue-type plasminogen activator (rt-PA), a thrombolytic, has been loaded into ELIP (Tiukinhoy-Laing et al. 2007). These vesicles have the potential to be used for ultrasound-enhanced thrombolysis in the treatment of acute ischemic stroke, myocardial infarction, deep vein thrombosis or pulmonary embolus. A clinical diagnostic ultrasound scanner (Philips HDI 5000; Philips Medical Systems, Bothell, WA, USA) equipped with a linear array transducer (L12-5) was employed for in vitro studies using rt-PA-loaded ELIP (T-ELIP). The goal of this study was to quantify ultrasound-triggered drug release from rt-PA-loaded echogenic liposomes. T-ELIP samples were exposed to 6.9-MHz B-mode pulses at a low pressure amplitude (600 kPa) to track the echogenicity over time under four experimental conditions: (1) flow alone to monitor gas diffusion from the T-ELIP, (2) pulsed 6.0-MHz color Doppler exposure above the acoustically driven threshold (0.8 MPa) to force gas out of the liposome gently, (3) pulsed 6.0-MHz color Doppler above the rapid fragmentation threshold (2.6 MPa) or (4) Triton X-100 to rupture the T-ELIP chemically as a positive control. Release of rt-PA for each ultrasound exposure protocol was assayed spectrophotometrically. T-ELIP were echogenic in the flow model (5 mL/min) for 30 min. The thrombolytic drug remained associated with the liposome when exposed to low-amplitude B-mode pulses over 60 min and was released when exposed to color Doppler pulses or Triton X-100. The rt-PA released from the liposomes had similar enzymatic activity as the free drug. These T-ELIP are robust and echogenic during continuous fundamental 6.9-MHz B-mode imaging at a low exposure output level (600 kPa). Furthermore, a therapeutic concentration of rt-PA can be released by fragmenting the T-ELIP with pulsed 6.0-MHz color Doppler ultrasound above the rapid fragmentation threshold (1.59 MPa). (E-mail: denise.smith@uc.edu).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19900755      PMCID: PMC3037723          DOI: 10.1016/j.ultrasmedbio.2009.08.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  36 in total

1.  Fundamental studies on contrast images from different-sized microbubbles: analytical and experimental studies.

Authors:  K Soetanto; M Chan
Journal:  Ultrasound Med Biol       Date:  2000-01       Impact factor: 2.998

2.  Mechanisms of contrast agent destruction.

Authors:  J E Chomas; P Dayton; J Allen; K Morgan; K W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2001-01       Impact factor: 2.725

3.  Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).

Authors:  Maher Saqqur; Georgios Tsivgoulis; Carlos A Molina; Andrew M Demchuk; Zsolt Garami; Andrew Barreto; Konstantinos Spengos; Alex Forteza; Robert Mikulik; Vijay K Sharma; Alex Brunser; Patricia Martinez; Joan Montaner; Martin Kohrmann; Peter D Schellinger; Andrei V Alexandrov
Journal:  Int J Stroke       Date:  2008-02       Impact factor: 5.266

4.  Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents.

Authors:  S L Huang; A J Hamilton; A Nagaraj; S D Tiukinhoy; M E Klegerman; D D McPherson; R C Macdonald
Journal:  J Pharm Sci       Date:  2001-12       Impact factor: 3.534

5.  Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents.

Authors:  Shao-Ling Huang; Andrew J Hamilton; Edwin Pozharski; Ashwin Nagaraj; Melvin E Klegerman; David D McPherson; Robert C MacDonald
Journal:  Ultrasound Med Biol       Date:  2002-03       Impact factor: 2.998

6.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

7.  Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction.

Authors:  Shuyuan Chen; Ralph V Shohet; Raffi Bekeredjian; Peter Frenkel; Paul A Grayburn
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes.

Authors:  Jonathan A Kopechek; Todd M Abruzzo; Boyu Wang; Stephen M Chrzanowski; Denise A B Smith; Patrick H Kee; Shaoling Huang; Joel H Collier; David D McPherson; Christy K Holland
Journal:  J Ultrasound Med       Date:  2008-11       Impact factor: 2.153

Review 9.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

10.  Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery.

Authors:  Patrick H Kee; Todd A Abruzzo; Denise A B Smith; Jonathan A Kopechek; Boyu Wang; Shaoling L Huang; Robert C MacDonald; Christy K Holland; David D McPherson
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

View more
  36 in total

1.  Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.

Authors:  Jonathan A Kopechek; Kevin J Haworth; Jason L Raymond; T Douglas Mast; Stephen R Perrin; Melvin E Klegerman; Shaoling Huang; Tyrone M Porter; David D McPherson; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2011-11       Impact factor: 1.840

2.  Passive imaging with pulsed ultrasound insonations.

Authors:  Kevin J Haworth; T Douglas Mast; Kirthi Radhakrishnan; Mark T Burgess; Jonathan A Kopechek; Shao-Ling Huang; David D McPherson; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2012-07       Impact factor: 1.840

3.  Efficacy of histotripsy combined with rt-PA in vitro.

Authors:  Kenneth B Bader; Kevin J Haworth; Himanshu Shekhar; Adam D Maxwell; Tao Peng; David D McPherson; Christy K Holland
Journal:  Phys Med Biol       Date:  2016-06-29       Impact factor: 3.609

Review 4.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 5.  For Whom the Bubble Grows: Physical Principles of Bubble Nucleation and Dynamics in Histotripsy Ultrasound Therapy.

Authors:  Kenneth B Bader; Eli Vlaisavljevich; Adam D Maxwell
Journal:  Ultrasound Med Biol       Date:  2019-03-26       Impact factor: 2.998

Review 6.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

8.  Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.

Authors:  Rahul Nahire; Shirshendu Paul; Michael D Scott; Raushan K Singh; Wallace W Muhonen; John Shabb; Kara N Gange; D K Srivastava; Kausik Sarkar; Sanku Mallik
Journal:  Mol Pharm       Date:  2012-08-15       Impact factor: 4.939

Review 9.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

10.  The impact of bubbles on measurement of drug release from echogenic liposomes.

Authors:  Jonathan A Kopechek; Kevin J Haworth; Kirthi Radhakrishnan; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland
Journal:  Ultrason Sonochem       Date:  2012-12-29       Impact factor: 7.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.